Table 3.
Hot Condition (38°C) |
Cool Condition (13°C) |
|||
---|---|---|---|---|
Before | After | Before | After | |
Ending rectal temperature, °C | ||||
HA | 39.5 ± 0.1 | 39.4 ± 0.2 | 38.8 ± 0.2 | 38.8 ± 0.1 |
Control | 39.3 ± 0.2 | 38.9 ± 0.1* | 38.9 ± 0.2 | 38.7 ± 0.2 |
Ending mean skin temperature, °C | ||||
HA | 34.8 ± 0.3 | 33.9 ± 0.2* | 24.1 ± 0.5 | 23.0 ± 0.3* |
Control | 34.7 ± 0.4 | 34.6 ± 0.2 | 23.7 ± 0.5 | 25.1 ± 0.7* |
Core-to-skin gradient, °C | ||||
HA | 4.7 ± 0.4 | 5.5 ± 0.3* | 14.7 ± 0.5 | 15.8 ± 0.3* |
Control | 4.6 ± 0.3 | 4.4 ± 0.2 | 15.0 ± 0.4 | 13.3 ± 0.6* |
Estimated skin blood flow, l/min | ||||
HA | 2.3 ± 0.2 | 2.3 ± 0.2 | 1.0 ± 0.1 | 1.0 ± 0.1 |
Control | 3.0 ± 0.3 | 2.8 ± 0.2 | 1.1 ± 0.1 | 1.3 ± 0.1* |
Ending mean body temperature, °C | ||||
HA | 38.7 ± 0.1 | 38.3 ± 0.2 | 35.9 ± 0.1 | 35.7 ± 0.1 |
Control | 38.5 ± 0.1 | 38.1 ± 0.1 | 35.9 ± 0.1 | 36.0 ± 0.1 |
Total body water loss, liters | ||||
HA | 1.8 ± 0.2 | 2.2 ± 0.2* | 1.1 ± 0.1 | 1.3 ± 0.1* |
Control | 1.9 ± 0.2 | 2.0 ± 0.2 | 1.1 ± 0.1 | 1.1 ± 0.1 |
Mean power output, W | ||||
HA | 201 ± 12 | 216 ± 14* | 246 ± 13 | 259 ± 14* |
Control | 208 ± 12 | 201 ± 12 | 249 ± 12 | 254 ± 14 |
Mean blood lactate, mmol/l | ||||
HA | 3.0 ± 0.3 | 3.2 ± 0.2 | 4.2 ± 0.4 | 4.7 ± 0.5 |
Control | 3.3 ± 0.4 | 2.3 ± 0.4 | 3.9 ± 0.3 | 3.6 ± 0.5 |
Mean cardiac output, l/min | ||||
HA | 20.1 ± 1.6 | 20.5 ± 1.4 | 22.3 ± 1.4 | 24.3 ± 1.5* |
Control | 22.6 ± 1.6 | 22.9 ± 1.8 | 25.0 ± 1.6 | 25.4 ± 1.9 |
Mean V̇o2, l/min | ||||
HA | 2.79 ± 0.22 | 2.90 ± 0.23* | 3.50 ± 0.20 | 3.78 ± 0.21* |
Control | 3.11 ± 0.16 | 2.97 ± 0.15 | 3.81 ± 0.19 | 3.73 ± 0.20 |
Mean RPE | ||||
HA | 16 ± 1 | 16 ± 1 | 16 ± 1 | 16 ± 1 |
Control | 16 ± 1 | 16 ± 1 | 15 ± 1 | 16 ± 1 |
Values are means ± SE for 12 subects in the experimental group and 8 subects in the control group. HA, heat acclimation. RPE, rating of received exertion.
P < 0.05 vs. preacclimation trial.